Natco Pharma informed that it has submitted the abbreviated new drug application (ANDA) with the United States Food and Drug Administration (USFDA) for Risdiplam for oral solution.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
